{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T17:09:39Z","timestamp":1793120979929,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T00:00:00Z","timestamp":1589241600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T00:00:00Z","timestamp":1589241600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001713","name":"European and Developing Countries Clinical Trials Partnership","doi-asserted-by":"crossref","award":["Career Development Fellowship - Training"],"award-info":[{"award-number":["Career Development Fellowship - Training"]}],"id":[{"id":"10.13039\/501100001713","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001713","name":"European and Developing Countries Clinical Trials Partnership","doi-asserted-by":"crossref","award":["Mobility Action Number 1027"],"award-info":[{"award-number":["Mobility Action Number 1027"]}],"id":[{"id":"10.13039\/501100001713","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Res Ther"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>The high rate of mortality among HIV-vertically infected adolescents might be favoured by HIV drug resistance (HIVDR) emergence, which calls for timeous actions in this underserved population. We thus sought to evaluate program quality indicators (PQIs) of HIVDR among HIV-vertically infected adolescents on antiretroviral therapy (ART).<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>A study was conducted in the Centre region of Cameroon among adolescents (10\u201319\u00a0years) receiving ART in two urban (The Mother\u2013Child Centre of the Chantal BIYA Foundation, the National Social Welfare Hospital) and three rural (Mfou District Hospital, Mbalmayo District Hospital and Nkomo Medical Center) health facilities. Following an exhaustive sampling from ART registers, patient medical files and pharmacy records, data was abstracted for seven PQIs: <jats:italic>on<\/jats:italic>-<jats:italic>time drug pick<\/jats:italic>-<jats:italic>up<\/jats:italic>; <jats:italic>retention in care; pharmacy stock outs<\/jats:italic>; <jats:italic>dispensing practices<\/jats:italic>; <jats:italic>viral load coverage<\/jats:italic>; <jats:italic>viral suppression and adequate switch to second<\/jats:italic>-<jats:italic>line<\/jats:italic>. Performance in PQIs was interpreted following the WHO-recommended thresholds (desirable, fair and\/or poor); with p\u2009&lt;\u20090.05 considered significant.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Among 967 adolescents (888 urban versus 79 rural) registered in the study sites, validated data was available for 633 (554 in urban and 79 in rural). Performance in the urban vs. rural settings was respectively: <jats:italic>on<\/jats:italic>-<jats:italic>time drug pick<\/jats:italic>-<jats:italic>up<\/jats:italic> was significantly poorer in rural (79% vs. 46%, p\u2009=\u20090.00000006); <jats:italic>retention in care<\/jats:italic> was fair in urban (80% vs. 72%, p\u2009=\u20090.17); <jats:italic>pharmacy stock outs<\/jats:italic> was significantly higher in urban settings (92% vs. 50%, p\u2009=\u20090.004); <jats:italic>dispensing practices<\/jats:italic> was desirable (100% vs. 100%, p\u2009=\u20091.000); <jats:italic>viral load coverage<\/jats:italic> was desirable only in urban sites (84% vs. 37%, p\u2009&lt;\u20090.0001); <jats:italic>viral suppression<\/jats:italic> was poor (33% vs. 53%, p\u2009=\u20090.08); <jats:italic>adequate switch to second<\/jats:italic>-<jats:italic>line<\/jats:italic> varied (38.1% vs. 100%, p\u2009=\u20090.384).<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>Among adolescents on ART in Cameroon, dispensing practices are appropriate, while adherence to ART program and viral load coverage are better in urban settings. However, in both urban and rural settings, pharmacy stock outs, poor viral suppression and inadequate switch to second-line among adolescents require corrective public-health actions to limit HIVDR and to improve transition towards adult care in countries sharing similar programmatic features.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12981-020-00270-7","type":"journal-article","created":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T09:04:16Z","timestamp":1589274256000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Programme quality indicators of HIV drug resistance among adolescents in urban versus rural settings of the centre region of Cameroon"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1501-2763","authenticated-orcid":false,"given":"Joseph","family":"Fokam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armanda","family":"Nangmo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlson","family":"Wandum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desire","family":"Takou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Mercedes","family":"Santoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Esther Njom","family":"Nlend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis Ndongo","family":"Ateba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul Koki","family":"Ndombo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelly","family":"Kamgaing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cedric","family":"Kamta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre","family":"Essiane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Lambo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Fokunang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dora","family":"Mbanya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorio","family":"Colizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo-Federico","family":"Perno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Ndjolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,12]]},"reference":[{"key":"270_CR1","doi-asserted-by":"publisher","unstructured":"Support WHO, Country FOR. Progress Report 2016. https:\/\/doi.org\/10.1371\/journal.pone.0079777(Epub ahead of print)","DOI":"10.1371\/journal.pone.0079777"},{"key":"270_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-14-196","author":"JM Juma","year":"2014","unstructured":"Juma JM, Tiberio JK, Abuya MI, et al. Monitoring prevention or emergence of HIV drug resistance: results of a population-based foundational survey of early warning indicators in mainland Tanzania. BMC Infect Dis. 2014. https:\/\/doi.org\/10.1186\/1471-2334-14-196(Epub ahead of print).","journal-title":"BMC Infect Dis"},{"key":"270_CR3","unstructured":"Unaids. UNAIDS Global statistics 2018. 2018; 1\u20135."},{"key":"270_CR4","first-page":"35","volume":"21","author":"AL Slogrove","year":"2018","unstructured":"Slogrove AL. Inequality in outcomes for adolescents living with perinatally acquired HIV in sub-Saharan Africa: a Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) Cohort Collaboration analysis: A. J Int AIDS Soc. 2018;21:35\u201346.","journal-title":"J Int AIDS Soc"},{"key":"270_CR5","unstructured":"Ki-moon B, Secretary-general UN. 2015 Statistical Update."},{"key":"270_CR6","unstructured":"AVERT. Young people, HIV and AIDS young people at school."},{"key":"270_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25041","author":"G Fatti","year":"2018","unstructured":"Fatti G, Jackson D, Goga AE, et al. The effectiveness and cost-effectiveness of community-based support for adolescents receiving antiretroviral treatment: an operational research study in South Africa. J Int AIDS Soc. 2018. https:\/\/doi.org\/10.1002\/jia2.25041(Epub ahead of print).","journal-title":"J Int AIDS Soc."},{"key":"270_CR8","unstructured":"WHO | Paediatric ARV Drug Optimization 2. WHO, 2015; http:\/\/www.who.int\/hiv\/pub\/meetingreports\/paediatric-arv-optimization\/en\/. Accessed 10 May 2018)."},{"key":"270_CR9","unstructured":"WHO. World Health Organization Global Strategy for the surveillance and monitoring of HIV drug resistance. Who; 2012. ISBN: 978 92 4 150476 8. (Epub ahead of print)"},{"key":"270_CR10","first-page":"8","volume":"21","author":"D Wun","year":"2018","unstructured":"Wun D, Cluver L, Luo C. Evolution or extinction? Paediatric and adolescent HIV responses in the Agenda 2030 era. J Int AIDS Soc. 2018;21:8\u201310.","journal-title":"J Int AIDS Soc"},{"key":"270_CR11","doi-asserted-by":"publisher","first-page":"e72680","DOI":"10.1371\/journal.pone.0072680","volume":"8","author":"SCSC Billong","year":"2013","unstructured":"Billong SCSC, Fokam J, Aghokeng AFAF, et al. Population-based monitoring of emerging HIV-1 drug resistance on antiretroviral therapy and associated factors in a Sentinel Site in Cameroon: low levels of resistance but Poor Programmatic Performance. PLoS ONE. 2013;8:e72680.","journal-title":"PLoS ONE"},{"key":"270_CR12","unstructured":"Cameroun \u2013 PopulationData.net, https:\/\/www.populationdata.net\/pays\/cameroun\/. Accessed 9 Oct 2018."},{"key":"270_CR13","unstructured":"UNAIDS data 2019."},{"key":"270_CR14","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1037\/0096-3445.136.1.23","volume":"136","author":"T Dalgleish","year":"2007","unstructured":"Dalgleish T, Williams JMG, Golden A-MJ, et al. J Exp Psychol Gen. 2007;136:23\u201342.","journal-title":"J Exp Psychol Gen"},{"key":"270_CR15","unstructured":"HIV\/AIDS Programme Assessment of World Health Organization HIV drug resistance early warning indicators, http:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/75186\/9789241503945_eng.pdf?sequence=1. Accessed 26 May 2018."},{"key":"270_CR16","unstructured":"WHO. Global Action Plan on HIV Drug 2018 Progress Report."},{"key":"270_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-13-308","author":"J Fokam","year":"2013","unstructured":"Fokam J, Billong SC, Bissek ACZK, et al. Declining trends in early warning indicators for HIV drug resistance in Cameroon from 2008\u20132010: lessons and challenges for low-resource settings. BMC Public Health. 2013. https:\/\/doi.org\/10.1186\/1471-2458-13-308Epub ahead of print.","journal-title":"BMC Public Health."},{"key":"270_CR18","doi-asserted-by":"publisher","first-page":"e0129210","DOI":"10.1371\/journal.pone.0129210","volume":"10","author":"J Fokam","year":"2015","unstructured":"Fokam J, Elat J-BN, Billong SC, et al. Monitoring HIV drug resistance early warning indicators in Cameroon: a study following the revised World Health Organization recommendations. PLoS ONE. 2015;10:e0129210.","journal-title":"PLoS ONE"},{"key":"270_CR19","unstructured":"World Health Organization. Consolidated guidelines on person\u2011centred HIV patient monitoring and case surveillance. Guidelines 2017;1\u2013224."},{"key":"270_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0166649","author":"N Mutenda","year":"2016","unstructured":"Mutenda N, Bukowski A, Nitschke AM, et al. Assessment of the World Health Organization\u2019s HIV drug resistance early warning indicators in main and decentralized outreach antiretroviral therapy sites in Namibia. PLoS ONE. 2016. https:\/\/doi.org\/10.1371\/journal.pone.0166649Epub ahead of print.","journal-title":"PLoS ONE"},{"key":"270_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0036777","author":"SC Billong","year":"2012","unstructured":"Billong SC, Fokam J, Nkwescheu AS, et al. Early warning indicators for HIV drug resistance in cameroon during the year 2010. PLoS ONE. 2012. https:\/\/doi.org\/10.1371\/journal.pone.0036777(Epub ahead of print).","journal-title":"PLoS ONE"},{"key":"270_CR22","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu109","author":"NM Dube","year":"2014","unstructured":"Dube NM, Tint KS, Summers RS. Early warning indicators for HIV drug resistance in adults in South Africa at 2 pilot sites, 2008\u20132010. Clin Infect Di. 2014. https:\/\/doi.org\/10.1093\/cid\/ciu109(Epub ahead of print).","journal-title":"Clin Infect Di"},{"key":"270_CR23","first-page":"944","volume":"100","author":"C Lertpiriyasuwat","year":"2017","unstructured":"Lertpiriyasuwat C, Teeraratkul A, Suchonwanich Y, et al. Monitoring HIV drug resistance: early warning indicators to assess performance of Thailand\u2019s Antiretroviral Treatment Program. J Med Assoc Thai. 2017;100:944\u201352.","journal-title":"J Med Assoc Thai"},{"key":"270_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0100539","author":"A Jonas","year":"2014","unstructured":"Jonas A, Sumbi V, Mwinga S, et al. HIV drug resistance early warning indicators in Namibia with updated World Health Organization guidance. PLoS ONE. 2014. https:\/\/doi.org\/10.1371\/journal.pone.0100539(Epub ahead of print).","journal-title":"PLoS ONE"},{"key":"270_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0065653","author":"A Jonas","year":"2013","unstructured":"Jonas A, Gweshe J, Siboleka M, et al. HIV drug resistance early warning indicators in Namibia for Public Health Action. PLoS ONE. 2013. https:\/\/doi.org\/10.1371\/journal.pone.0065653(Epub ahead of print).","journal-title":"PLoS ONE"},{"key":"270_CR26","doi-asserted-by":"publisher","DOI":"10.1097\/qai.0b013e3181f5376d","author":"SY Hong","year":"2010","unstructured":"Hong SY, Jonas A, Dumeni E, et al. Population-based monitoring of HIV drug resistance in Namibia with early warning indicators. J Acquir Immune Defic Syndr. 2010. https:\/\/doi.org\/10.1097\/qai.0b013e3181f5376d(Epub ahead of print).","journal-title":"J Acquir Immune Defic Syndr"},{"key":"270_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12887-019-1599-z","volume":"19","author":"J Fokam","year":"2019","unstructured":"Fokam J, Santoro MM, Takou D, et al. Evaluation of treatment response, drug resistance and HIV-1 variability among adolescents on first-and second-line antiretroviral therapy: a study protocol for a prospective observational study in the centre region of Cameroon (EDCTP READY-study). BMC Pediatr. 2019;19:1\u201311.","journal-title":"BMC Pediatr"},{"key":"270_CR28","first-page":"A58","volume":"4","author":"J Fokam","year":"2019","unstructured":"Fokam J, Takou D, Santoro M, et al. PO 8580 Treatment response among cameroonian adolescents receiving antiretroviral therapy in urban and rural settings: preliminary findings from the READY study. BMJ Glob Heal. 2019;4:A58.","journal-title":"BMJ Glob Heal"},{"key":"270_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-018-5964-x","author":"E Nasuuna","year":"2018","unstructured":"Nasuuna E, Kigozi J, Babirye L, et al. Low HIV viral suppression rates following the intensive adherence counseling (IAC) program for children and adolescents with viral failure in public health facilities in Uganda. BMC Public Health. 2018. https:\/\/doi.org\/10.1186\/s12889-018-5964-x(Epub ahead of print).","journal-title":"BMC Public Health."}],"container-title":["AIDS Research and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-020-00270-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12981-020-00270-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-020-00270-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T00:04:32Z","timestamp":1620777872000},"score":1,"resource":{"primary":{"URL":"https:\/\/aidsrestherapy.biomedcentral.com\/articles\/10.1186\/s12981-020-00270-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,12]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["270"],"URL":"https:\/\/doi.org\/10.1186\/s12981-020-00270-7","relation":{},"ISSN":["1742-6405"],"issn-type":[{"value":"1742-6405","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,12]]},"assertion":[{"value":"4 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The present survey was implemented under the EDCTP CDF-TMA 1027 READY-Study. Ethical clearance was obtained from the National Ethical Committee for Human Health Research (CNERSH\/No: 2018\/01\/981\/CE\/CNERSH\/SP). Administrative authorizations were also obtained from the Directors of all the respective study sites. As part of the project, informed consent was obtained from each study participant, and results were used for clinical utility.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no competing interest to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14"}}